Related Experiment Video
Updated: May 11, 2026
08:56
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Atrial fibrillation: inflammation in disguise?
K T Lappegård1, A Hovland, G A M Pop
1Coronary Care Unit, Division of Internal Medicine, Nordland Hospital, Bodø, Norway. knut.tore.lappegard@gmail.com
Scandinavian Journal of Immunology
|May 16, 2013
Summary
Inflammation plays a key role in atrial fibrillation (AF) and its complications. Anti-inflammatory therapies may offer new treatment options for this common heart rhythm disorder.
Area of Science:
- Cardiology
- Immunology
- Pharmacology
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia associated with significant risks, including heart failure and thromboembolism.
- Current treatments for AF, focusing on rate control and anticoagulation, provide incomplete protection against complications.
- Emerging evidence highlights the critical involvement of inflammatory processes in the pathogenesis and progression of AF.
Purpose of the Study:
- To review current understanding of inflammation's impact on AF occurrence, recurrence, perpetuation, and complications.
- To explore the potential of anti-inflammatory therapies in managing AF and its associated risks.
Main Methods:
- Literature review of recent scientific publications.
- Synthesis of data on inflammatory markers and pathways in AF.
- Analysis of studies investigating anti-inflammatory treatments for AF.
Main Results:
- Inflammation is implicated in the initiation, maintenance, and adverse outcomes of AF.
- Specific inflammatory mediators contribute to atrial remodeling and electrical instability.
- Preclinical and clinical studies suggest a therapeutic benefit of anti-inflammatory agents in AF.
Conclusions:
- Inflammation is a crucial factor in atrial fibrillation pathophysiology.
- Targeting inflammatory pathways represents a promising strategy for novel AF treatments.
- Further research is warranted to establish the efficacy and safety of anti-inflammatory therapies in AF management.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
09:17High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:22Pericarditis I: Introduction
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...